Tags: world health organization | who | warning | counterfeit | fake | copies | drugs

WHO Warns Against Fake Copies of Ozempic, Wegovy

World Health Organization logo on flag
(Dreamstime)

Thursday, 20 June 2024 02:37 PM EDT

The World Health Organization (WHO) on Thursday issued warnings on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Wegovy.

Surging demand has outpaced supply for Ozempic, Eli Lilly's Mounjaro and other GLP-1 drugs that promote weight loss, fueling a growing global market for counterfeit versions.

The WHO's alert addresses three falsified batches of semaglutide that were detected in Brazil and the UK in October 2023, and the United States in December 2023.

Semaglutide is not a WHO-recommended treatment for diabetes management due to its current high cost, but the agency said it was working on a rapid advice guideline on use of GLP-1 drugs for treatment of obesity and as part of a more comprehensive model of care.

Fake drugs could be harmful and if they do not have the necessary raw components, can lead to health complications resulting from unmanaged blood glucose levels or weight, the WHO said. Thursday's alert was its first official notice after the confirmation of some reports.

"Patients who are using these products can take actions such as buying medicines with prescriptions from licensed physicians and avoid buying medicines from unfamiliar or unverified sources, such as those that may be found online," the agency said.

Novo and Lilly have sued several entities to stop them from selling products claiming to contain the active ingredients tirzepatide and semaglutide that are used in their respective popular diabetes and weight-loss drugs.

Eli Lilly said on Thursday it was suing six more entities including medical spas and wellness centers for selling products claiming to contain tirzepatide.

© 2024 Thomson/Reuters. All rights reserved.


Health-News
The World Health Organization (WHO) on Thursday issued warnings on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Wegovy. Surging demand has outpaced supply for Ozempic, Eli Lilly's Mounjaro and...
world health organization, who, warning, counterfeit, fake, copies, drugs, semaglutide, novo nordisk, ozempic, wegovy
267
2024-37-20
Thursday, 20 June 2024 02:37 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved